Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of 7.41% and 3.11%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the ...

TMCI) on Tuesday reported a loss of $15.4 million in its third quarter. The Ponte Vedra, Florida-based company said it had a loss of 25 cents per share. The results surpassed Wall Street expectations.

Revenue for the third quarter of 2024 was $45.1 million, representing an increase of 11% compared to $40.8 million in the third quarter of 2023. The increase was driven by product mix shift that ...

Tactile Systems (TCMD) stock was downgraded by BTIG to neutral as its Q3 revenue misses expectations. Read more here.

Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH ...

With 3 analyst ratings, Treace Medical Concepts has a consensus rating of Neutral. The average one-year price target is $6.83, indicating a potential 42.89% upside.

Coda Octopus Group, Inc. ("CODA” or the "Company”) (Nasdaq: CODA), a global market leader in 3D/4D/5D/6D imaging sonar ...

News' Sharon Phillips' latest Cold Case investigation looks into the story of Gregory Treace who's been missing from Creek ...

Law Offices of Howard G. Smith announces an investigation on behalf of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ: TMCI) investors concerning the Company's possible violations ...

The Law Offices of Frank R. Cruz announces an investigation of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ: TMCI) on behalf of investors concerning the Company's possible ...